Scinai Immunotherapeutics (SCNI) Current Leases (2019 - 2025)
Scinai Immunotherapeutics (SCNI) reported Current Leases of $329000.0 for Q4 2025, down 22.41% on a YoY basis from $424000.0 in Q4 2024, and down 22.41% sequentially from $424000.0 in Q4 2024.
Scinai Immunotherapeutics (SCNI) Current Leases (2019 - 2025) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 7 years of Current Leases data on file, last reported at $329000.0 in Q4 2025.
- For the quarter ending Q4 2025, Current Leases fell 22.41% year-over-year to $329000.0; the trailing twelve-month figure through Dec 2025 stood at $329000.0 (down 22.41% YoY), and the FY2025 full-year result was $329000.0, down 22.41% from the prior year.
- Current Leases retreated to $329000.0 in Q4 2025, from $424000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $424000.0 in Q4 2024 to a low of $249000.0 in Q4 2021.
- A 5-year average of $356000.0 and a median of $382000.0 in 2022 frame the typical range for Current Leases.
- Across the five-year window, Current Leases soared 53.41% in 2022 and retreated 22.41% in 2025, its largest moves.
- Tracing SCNI's Current Leases over 5 years: stood at $249000.0 in 2021, then soared by 53.41% to $382000.0 in 2022, then advanced by 3.66% to $396000.0 in 2023, then advanced by 7.07% to $424000.0 in 2024, then fell by 22.41% to $329000.0 in 2025.
- Business Quant data shows SCNI's Current Leases at $329000.0 in Q4 2025, $424000.0 in Q4 2024, and $396000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 20.58 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 872,589.03 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.61 Mn |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 329,000.00 |
| Dec 31, 2024 | 424,000.00 |
| Dec 31, 2023 | 396,000.00 |
| Dec 31, 2022 | 382,000.00 |
| Dec 31, 2021 | 249,000.00 |
| Dec 31, 2020 | 203,000.00 |
| Dec 31, 2019 | 201,000.00 |